Fig. 3From: Rapid response of Nelson’s syndrome to pasireotide in radiotherapy-naive patientCoronal T1-weighted MRI scans. a and b. November 2019: Bilateral pituitary lesions measuring 14 mm and 7 mm indicative of recurrence of Nelson’s syndrome. Pasireotide was initiated one month after this imaging was completed. c and d. February 2020: Bilateral pituitary lesions measuring 13 mm and 6 mm after 2 months of pasireotide treatmentBack to article page